
Neuropsychotherapeutics
Description
Key Features
- Includes the authority and expertise of leading contributors in pharmacology
- Presents the latest release in the Advances in Pharmacology series
Readership
Investigators in neuroscience, pharmacology, neurology, psychiatry, medicine
Table of Contents
1. GPCR drug discovery-moving beyond the orthosteric to the allosteric domain
Christian C. Felder
2. Lipid rafts in psychiatry
Nathan H. Wray and Mark M. Rasenick
3. Rapid-acting antidepressants
Jeffrey M. Witkin, Anna E. Martin, Lalit K. Golani, Nina Z. Xu and Jodi L. Smith
4. mGlu2/3 receptor antagonists
Shigeyuki Chaki
5. Nitric oxide: Antidepressant mechanisms and inflammation
Mehdi Ghasemi
6. Selective allosteric modulation of muscarinic acetylcholine receptors for the treatment of schizophrenia and substance use disorders
Laura B. Teal, Robert W. Gould, Andrew S. Felts and Carrie K. Jones
7. Medications development for food-based and drug use disorders
Fernando B. de Moura, Stephen J. Kohut and Jack Bergman
8. Obsessive compulsive disorder (OCD): Current treatments and a framework for neurotherapeutic research
Erik Z. Woody, Kurt Leroy Hoffman and Henry Szechtman
9. Positive allosteric modulators of the dopamine D1 receptor: A new mechanism for the treatment of neuropsychiatric disorders
Kjell A. Svensson, Junliang Hao and Robert F. Bruns
Product details
- No. of pages: 320
- Language: English
- Copyright: © Academic Press 2019
- Published: August 1, 2019
- Imprint: Academic Press
- eBook ISBN: 9780128166697
- Hardcover ISBN: 9780128166680